News
ResMed Q4 Earnings Call Highlights
ResMed NYSE: RMD reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share
Rockwell Automation Q3 Earnings Call Highlights
Rockwell Automation NYSE: ROK reported third-quarter fiscal 2026 results that exceeded its expectations, supported by double-digit organic sales growth, stronger earnings and broad demand in several a
Regal Rexnord Q2 Earnings Call Highlights
Regal Rexnord NYSE: RRX reported second-quarter results marked by higher orders, organic sales growth and continued momentum in data center, automation and energy-related markets, while lowering certa
Republic Services Q2 Earnings Call Highlights
Republic Services NYSE: RSG raised its full-year 2026 outlook after reporting second-quarter revenue growth of 4.6% and adjusted EBITDA growth of 4.5%, supported by pricing, acquisitions and recycling
Revolve Group Q2 Earnings Call Highlights
Revolve Group NYSE: RVLV reported second-quarter 2026 net sales of $347 million, up 12% from a year earlier, as growth accelerated across its REVOLVE and FWRD segments, domestic and international mark
Revvity Q2 Earnings Call Highlights
Revvity NYSE: RVTY reported second-quarter results above its expectations and raised its full-year outlook, citing continued strength in diagnostics, improving demand from pharmaceutical and biotechno
RXO Q2 Earnings Call Highlights
RXO NYSE: RXO reported second-quarter results that exceeded its prior outlook, as brokerage volume growth, a larger mix of spot freight and stronger-than-expected last-mile stops supported profitabili
Rayonier Q2 Earnings Call Highlights
Rayonier NYSE: RYN reported second-quarter GAAP earnings of $19 million, or $0.06 per share, as contributions from the recently completed merger with PotlatchDeltic and stronger operating results acro
StandardAero Q2 Earnings Call Highlights
StandardAero NYSE: SARO reported second-quarter 2026 revenue growth, record adjusted EBITDA margins and positive free cash flow, while raising its full-year revenue, adjusted EBITDA and adjusted earni
Club Offers for Travel Enthusiasts in the U.S.
NEW YORK, Aug. 9, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces six of many new Club Offers for Club Members in the U.S. Rigorously vetted and negotiated f
AerSale: MRO Growth Must Overcome Poor Execution
AerSale remains a high-risk buy with a revised price target of $8.33–$9.36, reflecting discounted upside due to poor execution. Q2 results showed sharply lower revenue and EBITDA, driven by absent fli
Dr. Timothy Francis Scholarship for Medical Students Launches Application Window for Future Healthcare Leaders
Las Vegas, Nevada--(Newsfile Corp. - August 8, 2026) - The Dr. Timothy Francis Scholarship for Medical Students officially opens its
David Ebrahimzadeh Grant Launches Real Estate Innovation Scholarship for Undergraduate Students Nationwide
New York, New York--(Newsfile Corp. - August 8, 2026) - The David Ebrahimzadeh Grant, founded by entrepreneur, investor, and business
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Tra
FUTU FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Futu Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FUTU
NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and Ma
Arista Networks: Despite Clear AI Tailwinds, Gains Will Be More Limited Here (Downgrade)
Arista Networks has surged to all-time highs, driven by 40% revenue and earnings growth amid robust AI data center demand. ANET's 'AI spine' products have become the gold standard for modern data cen
NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day Transcript
NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day Transcript
Ready Capital Q2 Earnings Call Highlights
Ready Capital NYSE: RC said its second-quarter results reflected continued progress in a balance sheet repositioning plan, including portfolio sales, debt paydowns and new financing initiatives, as th
Arcus Biosciences Q2 Earnings Call Highlights
Arcus Biosciences NYSE: RCUS outlined plans to expand development of its casdatifan cancer program across multiple lines of clear cell renal cell carcinoma, or ccRCC, while reporting second-quarter fi
Radian Group Q2 Earnings Call Highlights
Radian Group NYSE: RDN reported second-quarter results that reflected its first full quarter including specialty insurer Inigo, while executives emphasized continued strength in mortgage insurance, pr
